MedTrace Logo

Assessment of Motor Development With a Wearable in Rural and Low-income Settings

NCT05782673 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2025-09-18

No results posted yet for this study

Summary

The MaMa study aims to assess feasibility and validity of an infant wearable in a rural settings. Altogether N\~100 infants will be recruited and measured multiple times at homes from age 6 months to age 18 months. Neurodevelopment of the infants is assessed at 18-24 months of age to compare motor development trajectories with the later neurodevelopmental outcome.

Conditions

  • Infant Development

Interventions

DEVICE

wearable MAIJU for motor assessment

The novel multisensor wearable MAIJU will be used to measure infants' motor performance at home. The recordings are repeated at 2 months intervals betveen 6 and 18 months of age.

Sponsors & Collaborators

  • Tampere University

    collaborator OTHER

  • University of Helsinki

    collaborator OTHER

  • Kamuzu University of Health Sciences

    collaborator OTHER

  • Helsinki University Central Hospital

    lead OTHER

Principal Investigators

  • Sampsa Vanhatalo, MD PhD · professor in physiology, consultant in clinical neurophysiology

Eligibility

Min Age
4 Months
Max Age
24 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-05-15
Primary Completion
2025-10-30
Completion
2025-12-31

Countries

  • Finland
  • Malawi

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05782673 on ClinicalTrials.gov